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Objective:  Heart  rate  variability  (HRV)  measures  are  altered  in  various  cardiac  and  non-cardiac  situations
in children.  The  autonomic  nervous  system  is  assumed  to  have  a role  in  the  pathophysiology  of  atrial
septal  defect  (ASD).  In this  study,  we  evaluated  the autonomic  system  by  measuring  HRV in children
with  ASD.
Methods:  Twenty-eight  patients  with  ASD  and  32 healthy  children  (mean  ages:  6.6  ± 2.1  years  and
6.4  ± 2.2  years,  respectively)  were  enrolled  in  the  study.  Twenty-four-hour  ambulatory  electrocardio-
graphic  recordings  were  obtained  and  the  seven  time-domain  (SDNN,  SDANN,  rMSSD,  SD, SDNN  index,ardiac autonomic function
eart rate variability
ower spectral analysis
ime-domain analysis
PNN50, and  mean  RR)  and four  frequency-domain  (VLF,  LF, HF, and LF/HF  ratio)  indices  of HRV  were
analyzed.
Results:  A  signiﬁcant  decrease  in  calculated  HRV  variables  was observed  in  children  with  ASD  as  compared
to controls.  The  HRV  alteration  was  found  in  both  time-domain  and  frequency-domain  parameters.
Conclusions:  Our  results  indicate  that  HRV  is  decreased  in children  with  ASD,  which  implies  parasympa-
thetic  withdrawal  and  sympathetic  predominance.
3  Jap©  201
ntroduction
Heart rate variability (HRV), deﬁned as degree of ﬂuctuation of
he beat-to-beat differences in cardiac rhythm, is known to be a
eliable, noninvasive marker of autonomic nervous system activity
1]. The loss of this beat-to-beat variability is indicative of various
iseases. Detection of such changes, especially for the evaluation
f autonomic nervous system functions, may  be used as a marker
f underlying pathology [2]. It is well known that the autonomic
ervous system may  contribute to pathological conditions such as
schemic heart disease, arrhythmia, and congestive heart failure,
nd inﬂuence the prognosis of these diseases [3,4].
The clinical assessment of the autonomic nervous system and
ts relationship with the cardiovascular system has become a major
eld of interest in cardiology in particular pediatric cardiology.
HRV, which is a noninvasive diagnostic method, has been used
o determine risk stratiﬁcation in cardiac diseases [5].
This study was designed to compare HRV in children with
trial septal defect (ASD) and normal children. Reduced HRV was
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observed in all children with ASD before treatment [6]. But we also
used frequency analysis (power spectral analysis) of the heart rate
of these children to describe the frequency components in their
HRV that reﬂects autonomic activity and to examine the possi-
ble effects of the ASD on autonomic regulation of the heart rate.
Because as time-domain and frequency-domain parameters are
related to each other, a change in one of them is generally sug-
gestive of a change in the other [7].
Therefore, the present cross-sectional, case–control study was
designed to evaluate cardiac autonomic functions and compare
HRV in children with ASD and to compare their variability with
that of normal children. We  also used frequency analysis (power
spectral analysis) of the heart rate of these children to describe the
frequency components in their HRV that reﬂect autonomic activity.
Materials and methods
Study design and patients
This cross-sectional study was conducted at the Unit of Pedi-
atric Cardiology of I˙stanbul University Cerrahpas¸ a Medical Faculty,
Istanbul, Turkey. Prior to subject recruitment, the study proto-
col was reviewed and approved by the local Ethics Committee,
in accordance with the ethical principles for human investiga-
tions, as outlined by the Second Declaration of Helsinki and written
vier Ltd. All rights reserved.
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nformed consent was obtained from all the patients. Between
ovember 2010 and January 2011, 28 consecutively age–gender-
atched ASD patients (Group 1) and 32 healthy controls (Group
) were recruited to the study. No evidence of structural car-
iovascular disease was detected by two-dimensional or Doppler
chocardiography in the control group.
Chest radiographs were evaluated and the majority were nor-
al  (66%), around 30% of patients had pulmonary conus increase,
nd 14% of patients showed a signiﬁcant increase in the cardiotho-
acic ratio. All patients and controls were required to have normal
inus rhythms to be eligible for inclusion and were excluded if they
ad a history of symptomatic arrhythmias or syncope, were taking
nti-arrhythmic drugs, had valvular heart disease, ischemic heart
isease, cardiomyopathies, or clinical evidence of heart failure. Nor-
al  electrocardiograms were recorded in 76% and 20% had right
undle branch block, 9% right ventricle strain and 5% were cases of
ight atrial dilatation. Patients with other congenital cardiac defects
ssociated with ASD were also excluded.
chocardiographic examination
A detailed echocardiography, which included an M-mode, two
imensional, color and Doppler (continuous and pulse wave) exam-
nation was performed. Images were obtained on a Siemens Acuson
V70 with a 4-2 MH  transducer (Siemens, Erlangen, Germany).
he patients were requested to rest for 5 min  before the mea-
urements and breathe slowly during the procedure. Recordings
ere performed with subjects in the supine or left lateral pos-
tions. M-mode tracings were obtained at the level of tips of mitral
eaﬂets in parasternal long axis position and measurements of
eft ventricular end-systolic dimension (LVESD), left ventricular
nd-diastolic dimension (LVEDD) were performed according to the
ecommendations of the American Society of Echocardiography [8].
entricular septal and posterior wall thickness at end-diastole, and
eft atrial dimension (LAD) were measured from parasternal long
xis window in M-mode echocardiography. Left ventricular ejec-
ion fraction (EF) and fractional shortening (FS) were obtained using
eichholtz in M-mode echocardiography.
olter monitoring
The tape recordings consisted of 3 channels of electrocardio-
raphic data and were analyzed with the use of Del Mar  Avionics
trata Scan model 563 Holter System (Irvine, CA, USA).
All data were reviewed by one analyst and edited. Artifacts and
ctopic complexes were excluded. The data was gathered while the
ubjects were in their normal daily activities and had normal sleep
nd wake patterns. There had to be 23 h of analyzable data for the
4-h recording to be accepted for the study. The raw electrocardio-
raphic data were digitized at a sampling rate of 128 Hz.
The 24-h ambulatory electrocardiography was  replayed through
 Del Mar  Holter analyzer (Model 563 Strata Scan analyzer Del Mar
vionics) to detect the presence of arrhythmias. Abnormal beats,
igniﬁcant pauses, and areas of artifacts were automatically and
ater manually identiﬁed and rejected. Recordings with signiﬁcant
rrhythmias, less than 18 h recording, or with less than 90% of the
ecording suitable for analysis were excluded to avoid effects due
o circadian variation in heart rate variability.
nalysis of recording
Measures of HRV were calculated employing only normal-to-
ormal intervals. For the analysis of the frequency-domain indices,
eat-to-beat ﬂuctuations were transformed to the frequency-
omain by fast Fourier transformation, and the speciﬁc measures
ere computed as the square root of the areas under the powerology 61 (2013) 436–439 437
spectrum. Recommendations of the Task Force on HRV [9] were
respected.
Indices of HRV
Seven time-domain (SDNN, SDANN, rMSSD, SD, SDNN index,
PNN50, and mean RR) and four frequency-domain indices (VLF, LF,
HF, and LF/HF ratio) were examined (see below).
Time domain measures were calculated for the entire duration
of recording. The indices taken were: SDNN, standard deviation of
all ﬁltered RR intervals in the entire period of recording, the SD of
all the normal RR intervals; SDANN, the SD of the means of all the
5-min segment normal RR intervals; SD, standard deviation of the
differences between adjacent RR intervals; SDNN index, mean of
the standard deviation of all RR intervals for all the 5 min  segments
of the entire recording; rMSSD, square root of the mean of the sum
of square differences between adjacent ﬁltered RR intervals over
the whole period of analysis; PNN50, percentage of the difference
between adjacent RR intervals that were greater than 50 ms  for the
whole period of analysis.
Among them, rMSSD, sNN50, and pNN50 primarily reﬂect
parasympathetically mediated changes in heart rate [10]. SDNN can
be inﬂuenced by parasympathetic and sympathetic stimulation.
The other time-domain variables reﬂect a mixture of parasympa-
thetic, sympathetic, and other physiological inﬂuences.
Frequency domain analysis was performed on a 300-s seg-
ment of data selected at the time of lowest heart rate during
the entire recording. Particularly a segment free of abnormal data
was chosen. We  determined spectral power over three frequency
regions of interest. VLF, very low frequency index [0.017–0.05 Hz];
LF, low frequency index [0.05–0.15 Hz]; HF, high frequency index
[0.15–0.50 Hz]. We  also determined the total power [all frequen-
cies greater than 0.017 Hz] and the ratio between low and high
frequency (LF/HF ratio).
The power associated with the low frequency and high fre-
quency peaks was  determined as the square root of the area under
each peak within 0–025 Hz of the low frequency peak and within
0–050 Hz of the high frequency peak. Area ratios L:H was  calculated.
Statistical analyses
All statistical analyses were performed using SPSS for Windows
version 11.0 (SPSS, Chicago, IL, USA). Continuous variables were
expressed as mean values plus or minus standard deviation, and
categorical variables as percentages. The chi-square test was used
to compare the categorical variables between groups. Independent
sample T-test was used to compare continuous variables between
groups. Two-sided p-value < 0.05 was considered statistically sig-
niﬁcant.
Results
The demographic characteristics of the study population are
summarized in Table 1. There was  no signiﬁcant difference between
the two  groups with regard to gender, age, or body surface area
(p > 0.05 for all). Table 2 shows the cardiovascular parameters
in ASD patients and controls. There were no signiﬁcant differ-
ences in heart rates and systolic-diastolic blood pressures between
the groups. Additionally, right atrium and right ventricle except,
left ventricle end-diastolic dimension, left ventricle end-systolic
dimension, left atrial dimension, aortic dimension, and left ven-
tricle ejection fraction-shortening fraction were similar between
the ASD patient group and control groups (Table 3). The mean ± SD
diameter of the ASD was  14.5 ± 5.7 mm (range 5–28 mm).
The mean duration of electrocardiography monitoring was
21.7 h in patients with ASD and 22.2 h in the control group (p = 0.14).
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Table  1
Demographic data of the study population.
ASD patients Control group p-Value
No. 28 32
Sex
Boys/Girls 15/13 17/15
Age (years)
Mean ± SD 6.6 ± 2.1 6.4 ± 2.2 NS
Height (cm)
Mean ± SD 123.18 ± 17.1 122.33 ± 15.8 NS
Weight (kg)
Mean ± SD 25.28 ± 12.3 26 ± 14.1 NS
BSA (m2)
Mean ± SD 1.12 ± 0.26 1.11 ± 0.27 NS
ASD, atrial septal defect; No., Number; BSA, body surface area; SD, standard devia-
tion; NS, nonsigniﬁcant
Table 2
Cardiovascular parameters in ASD patients and controls (mean ± SD).
ASD patients Control group p-Value
Diameter of ASD 14.5 ± 5.7 mm
(range 6–28 mm)
Heart rate (beat/min) 88.75 ± 16.39 87.62 ± 14.85 NS
Systolic blood pressure
(mmHg)
105.29 ± 12.52 104.67 ± 12.79 NS
Diastolic blood pressure
(mmHg)
69.20 ± 8.81 68.34 ± 9.12 NS
ASD, atrial septal defect; NS, non-signiﬁcant; SD, standard deviation.
Table 3
Echocardiographic parameters measured by M mode echocardiography
(mean ± SD).
Echocardiographic parameter ASD Controls p-Value
LVEDD (mm) 38.52 ± 5.2 37.72 ± 6.46 NS
LVESD (mm) 22.77 ± 3.85 23.69 ± 2.48 NS
IVS  thickness (mm)  6.89 ± 1.22 7.08 ± 0.58 NS
Posterior wall thickness (mm) 6.65 ± 1.19 6.73 ± 1.21 NS
Left atrial dimension (mm) 25.7 ± 3.91 24.44 ± 2.34 NS
Aorta dimension (mm) 22.11 ± 2.16 22.2 ± 2.65 NS
LVEF (%) 66.59 ± 7.22 66.46 ± 6.82 NS
LV  FS (%) 35.73 ± 6.19 35.66 ± 6.38 NS
RA  (mm)  29.24 ± 4.12 23.45 ± 3.45 0.001
RV  (mm) 33.97 ± 8.56 28.12 ± 4.52 0.001
ASD, atrial septal defect; LVEDD, left ventricular end-diastolic diameter; LVESD, left
ventricular end-systolic diameter; IVS, interventricular septum; LVEF, left ventricu-
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Table 4
Comparison of time domain measures between in patients with ASD and healthy
children.
Group 1 Group 2 p-Value˛
(n = 28) (n = 32)
SDNN (ms) 103 ± 50.61 138.66 ± 36.2 0.003
SDANN (ms) 81.14 ± 38.25 115.38 ± 30.36 0.002
rMSSD (ms) 41.34 ± 32.94 68.97 ± 34.21 0.002
SD (ms) 20.09 ± 11.48 27.43 ± 10.15 0.011
SDNN index (ms) 54.55 ± 37.80 74.9 ± 25.49 0.016
PNN50 (%) 13.59 ± 15.55 26.52 ± 12.93 0.001
Mean RR (ms) 617 ± 121.12 674.47 ± 62.13 0.001
All measurable values were given with mean ± standard deviation. SDNN, standard
deviation of all ﬁltered RR intervals in the entire period of recording; SDANN,
standard deviation of 5 minutes averages of RR intervals for the entire analysis; SD,
standard deviation of the differences between adjacent RR intervals; SDNN index,
mean of the standard deviation of all RR intervals for all the 5-minute segments
of  the entire recording; rMSSD, square root of the mean of the sum of square dif-
ferences between adjacent ﬁltered RR interval over the whole period of analysis;
PNN50, percentage of the difference between adjacent RR intervals that was greater
than 50 milliseconds for the whole period of analysis.
Independent sample T test˛ was  used.
Table 5
Comparison of frequency domain measures between in patients with ASD and
healthy children.
Group 1 Group 2 p-Value˛
(n = 28) (n = 32)
Total power (ms2) 2424 ± 4028.52 4668.22 ± 3168.56 0.022
VLF(ms2) 571.87 ± 1249.68 789.97 ± 812.8 0.426
LF (ms2) 811.61 ± 1783.28 968.77 ± 817.06 0.66
HF (ms2) 1090.21 ± 1880.83 2819.29 ± 2542.15 0.004
LF/HF ratio 0.88 ± 0.61 0.46 ± 0.44 0.004
All measurable values are given with mean ± standard deviation. VLF, Very low fre-ar  ejection fraction; LV FS, left ventricular fractional shortening; RA, right atrium;
V,  right ventricle; NS, nonsigniﬁcant; SD, standard deviation
able 4 shows the time domain variables differences between the
wo groups. Table 5 shows frequency domain variables differences
etween the two groups. The mean values of all time domain
ariables of heart rate variability were signiﬁcantly lower in ASD
atients than the normal children. Patients with ASD showed an
ncrease of LF/HF ratio and decreased HF. These changes were
tatistically signiﬁcant (respectively p = 0.004 and p = 0.004). The
ifferences were not signiﬁcant for VLF and LF variables between
he two groups (respectively p = 0.426 and p = 0.660).
iscussion
HRV depends on the inﬂuence of sympathetic and vagal activity
n the sinus node and reﬂects spontaneous changes in autonomic
ctivity. Sympatho-excitation characterizes heart disease: circulat-
ng levels of norepinephrine, vasopressin, and renin are elevated
nd arterial and cardiopulmonary baroreﬂex control of sympa-
hetic and parasympathetic activity is impaired [11]. There are no
imple means to characterize the degree of neurohumoral activa-
ion.quency index; LF, low frequency index; HF, high frequency index.
Independent sample T test˛ was  used.
Several authors have reported the harmful effect of increased
sympathetic activity and the protective role of vagal activ-
ity in patients with cardiovascular disease [12]. Treatment
modalities decreasing the sympathetic activity and/or increasing
parasympathetic activity by correcting the autonomic control of
cardiovascular system have been suggested to reduce cardiac death
[13].
ASD results in left-to-right shunting which, when signiﬁcant,
leads to right atrium (RA)/right ventricle (RV), and pulmonary arte-
rial dilation. It is now accepted that long-standing right heart,
pulmonary arterial and venous volume overload, and dilation in
the setting of an ASD is detrimental and leads to heart failure,
arrhythmia, and thromboembolic events and increased mortality
[14].
In our review of literature on HRV we found that the studies
done on patients with ASD before and after closure only the time
domain parameters were investigated [6,15]. In this study HRV in
patients with ASD before closure both the time domain measures
and frequency domain measures were investigated.
The results of our study show that both time-domain and
frequency-domain parameters of HRV were decreased in ASD
children – a ﬁnding, reﬂecting parasympathetic withdrawal and
sympathetic predominance. In the present study, indices of vagal
activity, such as SDNN, SDANN, SDNN index values, rMSSD, and
pNN50 values were reduced in the ASD group compared with
the control group. These ﬁndings showed an increase in sympa-
thetic control of the heart or a decrease in parasympathetic control
of the heart. A decrease in HRV is comparative to end-diastolic
pressure in the RV, so that RV volume overload possibly induces
ventricular baroreceptor dysfunction and this directly inﬂuences
sympathicovagal balance. Horner et al. [16] have shown in pig
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earts that increased mechanical stretch of the volume-overloaded
A on the sino-atrial nodal area could alter HRV by a direct effect
n diastolic depolarization within sino-atrial pacemaker cells via
tretch-activated channels or a reﬂex-mediated response to affer-
nt signals via neuronal stretch receptors. Atrial arrhythmias in
SD patients are the by-product of long-standing RA dilation and
tretch [17]. Atrial tachyarrhythmias are common among adults
ith secundum ASD and contribute to substantial cardiac morbid-
ty [14]. Edwards et al. have shown that atrial stretch is the principal
timulus for atrial natriuretic peptide secretion [18]. These ﬁndings
trengthen the likelihood that reduction in volume and pressure
s well as neurohumoral factors inﬂuence improvement in HRV.
revious studies have demonstrated that vagal activity and indices
f HRV are reduced in ASD, with the change dependent on the
xtent of hemodynamic disturbances, expressed by variables such
s elevated RV ﬁlling pressure and pulmonary arterial hyperten-
ion [19]. Similarly, in the present study, indices of vagal activity,
uch as SDNN, SDANN, and SDNN index values, were reduced in
he ASD group compared with the control group, whereas there
ere no changes in rMSSD and NN50 values, which are indices of
arasympathetic system activity.
We  used spectral analysis to study HRV in these patients because
f its potential to identify autonomic abnormalities of heart rate
ontrol that could also be responsible for decreased heart rate vari-
bility. One method used for quantitative assessment of vagal nerve
ctivity is the frequency-domain method [20]. HRV in people of all
ges has two main frequencies of variation: a HF band, 0.15–0.45 Hz
3 s period) and LF band, 0.03–0.15 Hz (12 s period) [21].
Frequency domain methods are used to study heart rate vari-
tions by breaking the heart rate signal into its constituents
frequencies) and quantifying their relative intensity (power). The
rominence of these two frequency bands in HRV can be expressed
y amplitude in the power spectrum. We  used power spectral
nalysis of heart rate with parameters of LF which are related to
aroreceptor control and are dually mediated by vagal and sym-
athetic systems, as well as those of HF which reﬂect respiratory
inus arrhythmia and thus, cardiac vagal activity. Also, the most
ndicative parameter of LF/HF was used for assessing the autonomic
alance.
In brief, the high frequency band corresponds to the respiratory
requency and is known to accurately reﬂect vagal nerve activity
20,22]. The low frequency peak seems to be mediated by both the
ympathetic and parasympathetic systems [22]. A change in peak
mplitude may  be caused by changes in coupling between respi-
ation and the heart or changes in autonomic control. The basic
isadvantage of this method was its complexity and inﬂuence by
reathing rate.
Tachycardia is associated with increase in the LF and a decrease
n the HF variables. Also ASD dampens the respiratory ﬂuctuations
f the RA volume because of the communication between right and
eft atrium. HF is mainly modulated by respiratory ﬂuctuations and
ampening of these ﬂuctuations in patients with ASD would lead
o a decrease in HF variables. In ASD the RA is larger than in normal
hildren and due to this, the inspiratory increase of the RA volume
s proportionately less than that occurring in the normal atrium and
his could explain the decrease of variability of the heart rate.
LF/HF ratio has been proposed as an index of sympathetic activ-
ty to the heart. The LF/HF ratio could express the complex relation
etween sympathetic activation and depression of the neural sym-
athetic modulation of the heart, the progressive reduction of the
ther HRV parameters reﬂecting then the loss of neural control
f the sinus node caused by the progressive increase of plasma
orepinephrine levels.
Our ﬁndings revealed reduced parasympathetic activity result-
ng in sympathetic predominance. However, in evaluating the
utonomic nervous system, we used only time-domain and
[ology 61 (2013) 436–439 439
frequency-domain parameters of HRV; therefore, we  cannot report
any conclusions pertaining to the mechanism of this cardiac
autonomic imbalance. The major advantage of the study was
the available of frequency-domain measures. Experience with
frequency domain analysis over the past two decades strongly sug-
gests that it represents a unique, noninvasive tool for achieving a
more precise assessment of autonomic function in both the exper-
imental and clinical settings.
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